TILT Holdings Announces New Independent Board Member
CAMBRIDGE, Mass., April 06, 2020 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (CSE: TILT) (OTCQB: TLLTF), a […]
SJI Provides Business Update Related to COVID-19 Pandemic Actions
Folsom, NJ , April 06, 2020 (GLOBE NEWSWIRE) — [...]
AgraFlora progresse vers l’octroi d’une licence à sa serre de 2,2 millions de pieds carrés située à Delta
VANCOUVER, Colombie-Britannique, 06 avr. 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE : AGRA) (Frankfurt: PU31) […]
Rockcliff Announces Commencement of Preliminary Economic Assessment and Provides Corporate Update
SUDBURY, Ontario, April 06, 2020 (GLOBE NEWSWIRE) — Rockcliff Metals Corporation (“Rockcliff” or the “Company”) (CSE: RCLF) (FRANKFURT: RO0, WKN: […]
California Bank of Commerce Launches Sponsor Finance Division
OAKLAND, Calif., April 06, 2020 (GLOBE NEWSWIRE) — California Bank of Commerce (CBC) announces the launch of its Sponsor Finance […]
GSK and Vir Biotechnology enter collaboration to find coronavirus solutions
Companies will combine their unique scientific and technical expertise to combat COVID-19 and potential future coronavirus outbreaksPromising antibody candidates for […]
Paul Fonteyne Joins Apellis Board of Directors
WALTHAM, Mass., April 06, 2020 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company pioneering targeted C3 therapies, […]
Catalyst Biosciences Announces Pivotal Phase 3 Study Design for MarzAA in Individuals with Hemophilia A or B with Inhibitors
SOUTH SAN FRANCISCO, Calif., April 06, 2020 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO), a biopharmaceutical company that is […]
Quotient Limited Announces the Completion of the SARS-CoV-2 Antibody Test Development
JERSEY, Channel Islands, April 06, 2020 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, […]
RedHill Biopharma Announces Approval of Compassionate Use of Opaganib for COVID-19 in Italy
Authorization of compassionate use granted by the Italian authorities, aided by RedHill’s strategic partner, Cosmo Pharmaceuticals N.V. (SIX: COPN)Approximately 160 […]
